Literature DB >> 22110210

Down-regulation of MiR-206 promotes proliferation and invasion of laryngeal cancer by regulating VEGF expression.

Tianhong Zhang1, Ming Liu, Chunrui Wang, Chao Lin, Yanan Sun, Dejun Jin.   

Abstract

MicroRNAs (miRNA) are a class of small noncoding RNAs that regulate the expression of their target genes. The aim of the present study was to explore the effects of miR-206 on laryngeal suamous cell carcinoma (LSCC) cells. The expression level of miR-206 was quantified by qRT-PCR in primary LSCC tissues and corresponding adjacent non-neoplastic tissues. MTT, Matrigel invasion assays and flow cytometry methods were used to test the proliferation, invasion and apoptosis of MiR-206 transfection LSCC cells and a mouse model was used to investigate tumorigenesis. MiR-206 was significantly down regulated in the LSCC tissues. Inverse correlation of miR-206 expression was found with the T grade, nodal metastasis and clinical stage of LSCC. Cell proliferation, migration, invasion and tumorigenesis in the LSCC cells were significantly inhibited and apoptotic cells were also increased after miR-206 tansfection. Furthermore, miR-206 transfection down-regulated the expression of vascular endothelial growth factor (VEGF) in the LSCC cells. The loss of miR-206 may play an important role in the progress of LSCC and miR-206 may function as a novel tumor suppressed miRNA.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22110210

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  68 in total

1.  MiR-203 is downregulated in laryngeal squamous cell carcinoma and can suppress proliferation and induce apoptosis of tumours.

Authors:  Linli Tian; Minghua Li; Jingchun Ge; Yan Guo; Yanan Sun; Ming Liu; Hui Xiao
Journal:  Tumour Biol       Date:  2014-04-01

2.  MicroRNA-206 prevents the pathogenesis of hepatocellular carcinoma by modulating expression of met proto-oncogene and cyclin-dependent kinase 6 in mice.

Authors:  Heng Wu; Junyan Tao; Xiaolei Li; Tianpeng Zhang; Lei Zhao; Yao Wang; Lei Zhang; Jun Xiong; Zhi Zeng; Na Zhan; Clifford J Steer; Li Che; Mingjie Dong; Xiaomei Wang; Junqi Niu; Zhuoyu Li; Guiqing Yan; Xin Chen; Guisheng Song
Journal:  Hepatology       Date:  2017-10-30       Impact factor: 17.425

3.  Decreased serum microRNA-206 level predicts unfavorable prognosis in patients with melanoma.

Authors:  Rong Tian; Tao Liu; Li Qiao; Mei Gao; Jing Li
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

4.  Role of miR206 in genistein-induced rescue of pulmonary hypertension in monocrotaline model.

Authors:  Salil Sharma; Soban Umar; Alexander Centala; Mansoureh Eghbali
Journal:  J Appl Physiol (1985)       Date:  2015-10-15

5.  Clinicopathological and prognostic significance of microRNA-107 in human non small cell lung cancer.

Authors:  Kai-Ze Zhong; Wei-Wen Chen; Xiao-Yan Hu; An-Li Jiang; Jian Zhao
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

Review 6.  MicroRNAs as regulators of cutaneous wound healing.

Authors:  Wing-Fu Lai; Parco M Siu
Journal:  J Biosci       Date:  2014-06       Impact factor: 1.826

7.  MicroRNA-205 suppresses proliferation and promotes apoptosis in laryngeal squamous cell carcinoma.

Authors:  Linli Tian; Jiarui Zhang; Jingchun Ge; Hui Xiao; Jianguang Lu; Songbin Fu; Ming Liu; Yanan Sun
Journal:  Med Oncol       Date:  2013-12-03       Impact factor: 3.064

Review 8.  MicroRNAs in laryngeal cancer: implications for diagnosis, prognosis and therapy.

Authors:  Pei Li; Hui Liu; Zhiyuan Wang; Feng He; Haifeng Wang; Zhi Shi; Ankui Yang; Jin Ye
Journal:  Am J Transl Res       Date:  2016-05-15       Impact factor: 4.060

Review 9.  Roles of the canonical myomiRs miR-1, -133 and -206 in cell development and disease.

Authors:  Keith Richard Mitchelson; Wen-Yan Qin
Journal:  World J Biol Chem       Date:  2015-08-26

Review 10.  MicroRNAs as diagnostic and prognostic biomarkers in colorectal cancer.

Authors:  Rui Yi; Yao Li; Fei-Liang Wang; Gang Miao; Ruo-Mei Qi; Yan-Yang Zhao
Journal:  World J Gastrointest Oncol       Date:  2016-04-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.